¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå ¿¹Ãø(-2031³â) : Áö¿ªº° ºÐ¼® - ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õº°, ¿ëµµº°
Asia Pacific Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)
»óǰÄÚµå : 1597167
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 93 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,450 £Ü 4,751,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 4,450 £Ü 6,128,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,450 £Ü 7,505,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀåÀº 2023³â 98¾ï 1,413¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2031³â¿¡´Â 165¾ï 1,017¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 6.7%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

°Ë»ç±â°üÀÇ Àü·«Àû ³ë·ÂÀ¸·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå ¼ºÀå ÃËÁø

Ç¥ÁØ ½ÇÇè½Ç Àμö, Á¦ÈÞ ¹× È®Àå°ú °°Àº °Ë»ç ¼­ºñ½º Á¦°ø¾÷üÀÇ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê´Â ´õ ³ªÀº ȯÀÚ Ä¡·á¿Í ºñ¿ë È¿À²¼ºÀ̶ó´Â ÇýÅÃÀ» ¾òÀ» ¼ö ÀÖ´Â °¡Àå ºñ¿ë È¿À²ÀûÀÎ ¹æ¹ý Áß ÇϳªÀÔ´Ï´Ù. 2024³â ÇÏ¿ìÁ¨-¹ø½ºÅ¸ÀÎÀº ű¹ ü¿ÜÁø´Ü¿ë ÀǾàǰ(IVD)ÀÇ ¼±µµÀûÀÎ °ø±Þ¾÷üÀÌÀÚ Àεµ ¹× µ¿³²¾Æ½Ã¾ÆÀÇ ½ÃÀå Á¢±Ù ¹× À¯Åë »ç¾÷¿¡¼­ ¸í¼ºÀ» ¾ò°í ÀÖ´Â ¿¡¹ö¶óÀÌÇÁ Ȧµù½º(Everlife Holdings Pte Ltd.)¿¡ ÀμöµÇ¾ú½À´Ï´Ù. 2024³â, Àεµ¿¡ º»»ç¸¦ µÐ ¾à¹° ¼±Åà ¹× Áúº´ °èÃþÈ­¸¦ À§ÇÑ Â÷¼¼´ë Áø´Ü¾àÀÎ CORE Diagnostics´Â 50°³ µµ½Ã·Î »ç¾÷À» È®ÀåÇÒ °èȹÀ» ¹ßÇ¥Çß½À´Ï´Ù. 2023³â Suburban Diagnostics´Â ¹³¹ÙÀÌÀÇ Vidya Vihar¿¡ ÃÖ´ë ±Ô¸ðÀÇ '·¹ÆÛ·±½º' ½ÇÇè½ÇÀ» °³¼³ÇÒ ¿¹Á¤ÀÔ´Ï´Ù. ÀÌ ÃÊÇö´ë½Ä °Ë»ç½ÇÀº ÃÖ÷´Ü °Ë»ç ±â¼ú°ú ÇÁ·Î¼¼½º ÀÚµ¿È­ ±â¼úÀ» Ȱ¿ëÇÏ¿© Á¤È®ÇÏ°í ½Å¼ÓÇÑ Áø´ÜÀ» À§ÇÑ Á¾ÇÕÀûÀÎ °Ë»ç ¸Þ´º¸¦ Á¦°øÇÕ´Ï´Ù. 2023³â Àεµ ÇÏÀ̵¥¶ó¹Ùµå¿¡ À§Ä¡ÇÑ ÀÓ»ó Ç¥ÁØ ½ÇÇè½ÇÀÎ TRUSTlab Diagnostics´Â Gurugram¿¡ À§Ä¡ÇÑ NKV Path Labs¿Í ÆÄÆ®³Ê½ÊÀ» ¸Î°í ±¹³» ¹ÌÃæÁ· Áö¿ªÀ¸·Î Áø´Ü ¼­ºñ½º¸¦ È®´ëÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ·¹ÆÛ·±½º ·¦ÀÇ Àμö ¹× Á¦ÈÞ Áõ°¡´Â ½ÃÀå ¼ºÀå¿¡ Å« ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå °³¿ä

ÃÖ±Ù ¼ö½Ê ³â µ¿¾È COVID-19¿Í ¿ø¼þÀÌ ¼öµÎ¸¦ Æ÷ÇÔÇÑ ¿©·¯ °¡Áö Àü¿°º´ÀÌ ÃâÇöÇÏ¿© Àηù °Ç°­¿¡ »õ·Î¿î À§ÇèÀ» ÃÊ·¡Çß½À´Ï´Ù. Áß±¹Àº ±Þ¼ÓÇÑ ¿ªÇÐÀû º¯È­¸¦ °Þ°í ÀÖÀ¸¸ç, Àü¿°º´ ´ëÃ¥ÀÌ ´«¿¡ ¶ç°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. Àü¿°º´ ¹®Á¦¸¦ ´Ù·ê ¶§ °¨¿° È®»êÀ» ÃÖ¼ÒÈ­Çϰí Àü¿°º´À» ¿¹¹æÇϰí ÅëÁ¦Çϱâ À§ÇØ °¡´ÉÇÑ ÇÑ »¡¸® ¹ßº´À» ¹ß°ßÇϰí, À§Ä¡¸¦ ÆÄ¾ÇÇϰí, º´¿øÃ¼¸¦ ½Äº°Çϰí, ÀûÀýÇÑ Ã³ºÐÀ» º¸ÀåÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. º´¿ø±ÕÀ» °ËÃâÇϱâ À§ÇØ º´¿ø°ú Ç¥ÁØ ½ÇÇè½Ç¿¡¼­ ´Ù¾çÇÑ °Ë»ç¸¦ ½Ç½ÃÇÕ´Ï´Ù. Áö¹æÁ¤ºÎ ÇàÁ¤±¸¿ª(PLADs)¿¡ µû¸£¸é 2014³âºÎÅÍ 2021³â±îÁö 5,770°ÇÀÇ ¸»¶ó¸®¾Æ »ç·Ê°¡ ±â·ÏµÇ¾ú°í, 99.05%ÀÇ ¸»¶ó¸®¾Æ Ç¥º»ÀÌ Áö¹æ ¸»¶ó¸®¾Æ Áø´Ü Ç¥ÁØ °Ë»ç½Ç¿¡ Á¦ÃâµÇ¾ú½À´Ï´Ù. Áö¹æ ¸»¶ó¸®¾Æ Áø´Ü Ç¥ÁØ ½ÇÇè½ÇÀº ÀÇ·á ½Ã¼³¿¡¼­ ¿øÃæ Áø´ÜÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀ» º¸ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. À§ÀÇ ¿äÀεéÀÌ ±¹³» ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå ¸ÅÃâ ¹× 2031³â±îÁöÀÇ ¿¹Ãø(¹é¸¸ ´Þ·¯)

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå ¼¼ºÐÈ­

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀåÀº ¼­ºñ½º Á¦°ø¾÷ü, ¿ëµµ, ±¹°¡º°·Î ºÐ·ùµË´Ï´Ù.

¼­ºñ½º Á¦°ø¾÷ü¸¦ ±âÁØÀ¸·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀåÀº º´¿ø ±â¹Ý, µ¶¸³Çü, Ŭ¸®´Ð ±â¹ÝÀ¸·Î ±¸ºÐµË´Ï´Ù. º´¿ø ±â¹Ý ºÎ¹®ÀÌ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¿ëµµº°·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀåÀº ÀÓ»ó°Ë»ç, ÀÓ»ó½ÃÇè, ±âŸ·Î ºÐ·ùµÇ¸ç, 2023³â ÀÓ»ó°Ë»ç ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀåÀº Áß±¹, ÀϺ», Àεµ, È£ÁÖ, Çѱ¹ ¹× ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀ¸·Î ±¸ºÐµÇ¸ç, 2023³â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå Á¡À¯À²Àº Áß±¹ÀÌ µ¶Â÷ÁöÇß½À´Ï´Ù.

Sonic Healthcare Ltd, Laboratory Corp of America Holdings, Quest Diagnostics Inc, Myraid Genetics Inc´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ

Á¦5Àå ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå : ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ºÐ¼®

Á¦6Àå ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå ºÐ¼® : ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õº°

Á¦7Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå : ±¹°¡º° ºÐ¼®

Á¦9Àå ÀÓ»ó Ç¥ÁØ ½ÇÇè½Ç ½ÃÀå - ¾÷°è »óȲ

Á¦10Àå ±â¾÷ °³¿ä

Á¦11Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Asia Pacific clinical reference laboratory market was valued at US$ 9,814.13 million in 2023 and is expected to reach US$ 16,510.17 million by 2031; it is estimated to register a CAGR of 6.7% from 2023 to 2031.

Strategic Initiatives with Reference Laboratories Boost Asia Pacific Clinical Reference Laboratory Market

Strategic initiatives by the laboratory service providers such as acquisition, alliance, and expansion with reference labs are among the most cost-effective ways to obtain the benefits of better patient care and cost efficiency. In 2024, Hausen-Bernstein Co. Ltd., the leading supplier of in-vitro diagnostic ("IVD") products in Thailand, was acquired by Everlife Holdings Pte Ltd, a prominent market access and distribution business in India and Southeast Asia. In 2024, CORE Diagnostics, a next-generation diagnostics for medication selection and disease stratification based in India, announced its plans to expand operations in 50 new cities. In 2023, Suburban Diagnostics opened its largest 'reference' laboratory in Vidya Vihar, Mumbai. This ultramodern laboratory will utilize state-of-the-art testing and process automation technologies to provide a comprehensive test menu for accurate and quick diagnosis. In 2023, TRUSTlab Diagnostics, a clinical reference laboratory in Hyderabad, India, partnered with NKV Path Labs in Gurugram to expand its diagnostic services to underserved areas of the nation. Thus, the increasing number of acquisitions and alliances with reference laboratories is expected to offer significant opportunities for market growth.

Asia Pacific Clinical Reference Laboratory Market Overview

In recent decades, the emergence of several infectious illnesses, including COVID-19 and monkeypox, has posed a new risk to human health. China has experienced a rapid epidemiological change, with notable advances in infectious disease control. When dealing with infectious disease concerns, it is critical to detect and locate the outbreak as soon as possible, identify the pathogen, and ensure proper disposal to minimize escalation and prevent and manage infectious diseases. Various tests are done in hospitals or reference laboratories to detect the pathogen. According to the provincial-level administrative divisions (PLADs), 5,770 malaria cases were recorded between 2014 and 2021, with 99.05% samples of malaria submitted to provincial malaria diagnosis reference laboratories. Provincial malaria diagnosis reference laboratories have played a critical role in guaranteeing the accuracy and reliability of Plasmodium diagnosis in healthcare facilities. The abovementioned factors are driving the clinical reference laboratory market in the country.

Asia Pacific Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Clinical Reference Laboratory Market Segmentation

The Asia Pacific clinical reference laboratory market is categorized into service provider, application, and country.

Based on service provider, the Asia Pacific clinical reference laboratory market is segmented into hospital-based, standalone, and clinic-based. The hospital-based segment held the largest market share in 2023.

In terms of application, the Asia Pacific clinical reference laboratory market is categorized into laboratory medicine, clinical trials, and others. The laboratory medicine segment held the largest market share in 2023.

By country, the Asia Pacific clinical reference laboratory market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific clinical reference laboratory market share in 2023.

Sonic Healthcare Ltd, Laboratory Corp of America Holdings, Quest Diagnostics Inc, and Myraid Genetics Inc are some of the leading companies operating in the Asia Pacific clinical reference laboratory market.

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Asia Pacific Clinical Reference Laboratory Market - Key Market Dynamics

5. Clinical Reference Laboratory Market - Asia Pacific Analysis

6. Clinical Reference Laboratory Market Analysis - by Service Provider

7. Asia Pacific Clinical Reference Laboratory Market Analysis - by Application

8. Asia Pacific Clinical Reference Laboratory Market - Country Analysis

9. Clinical Reference Laboratory Market-Industry Landscape

10. Company Profiles

11. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â